巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Johnson & Johnson

    JNJ
    179.530
    0.080
    0.04%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Johnson & Johnson - 延遲價格・最後更新於 26/05 12:14
    最高位
    180.990
    最低位
    178.630
    開市價
    --
    前收市價
    179.610
    成交量(千)
    283.53
    成交額(百萬)
    441.27
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    472,415.57
    市盈率
    24.200
    息率
    2.40%
    差價
    --
    52週高低
    186.690 - 155.720
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Johnson & Johnson
    證券代碼
    JNJ.US
    所屬板塊
    Drug Manufacturers - General
    公司業務
    Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total sales are generated in the United States.
    發行量
    2629268158
    公司總部
    One Johnson and Johnson Plaza
    公司網址
    https://www.jnj.com
    公司電話
    +1 732 524-0400

    美股異動 | 強生盤前跌1%,因存在出現血栓風險,FDA限制強生新冠疫苗接種

    格隆匯·
    美股異動 | 強生盤前跌1%,因存在出現血栓風險,FDA限制強生新冠疫苗接種

    美股異動 | 強生盤前跌1%,因存在出現血栓風險,FDA限制強生新冠疫苗接種

    格隆匯·
    美股異動 | 強生盤前跌1%,因存在出現血栓風險,FDA限制強生新冠疫苗接種

    強生疫苗或有血栓風險 美國FDA限制使用

    許懿安·
    強生疫苗或有血栓風險 美國FDA限制使用

    由於存在出現血栓風險 美國藥管侷限制強生新冠疫苗接種

    格隆匯·
    由於存在出現血栓風險 美國藥管侷限制強生新冠疫苗接種

    關於

    Johnson & Johnson(JNJ.US)所屬的行業板塊為Drug Manufacturers - General。
    Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total sales are generated in the United States.
    截至26/05 12:14:59,Johnson & Johnson的股價跌-0.04,市值472,415.57百萬。Johnson & Johnson的市盈率及息率分別為24.200及2.40%。
    詳細公司背景可參考: https://www.jnj.com